Plante Moran Financial Advisors’s Pacific Biosciences PACB Stock Holding History

Plante Moran Financial Advisors’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,450	Closed	-$5.25K	–	836
2025 Q1	$5.25K	Buy	4,450 +3,340	+301%	+$5.12K	﹤0.01%	640
2024 Q4	$2.03K	Hold	1,110	–	–	﹤0.01%	779
2024 Q3	$1.89K	Hold	1,110	–	–	﹤0.01%	759
2024 Q2	$1.52K	Hold	1,110	–	–	﹤0.01%	715
2024 Q1	$4.16K	Hold	1,110	–	–	﹤0.01%	704
2023 Q4	$10.9K	Hold	1,110	–	–	﹤0.01%	547
2023 Q3	$9.27K	Hold	1,110	–	–	﹤0.01%	538
2023 Q2	$14.8K	Hold	1,110	–	–	﹤0.01%	499
2023 Q1	$12.9K	Hold	1,110	–	–	﹤0.01%	522
2022 Q4	$9.08K	Hold	1,110	–	–	﹤0.01%	593
2022 Q3	$6K	Buy	+1,110	New	+$6.37K	﹤0.01%	666

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Plante Moran Financial Advisors's PACB Position: Q2 2025 in Review

Plante Moran Financial Advisors sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 4,450 shares — an estimated $5.25K sold.

Plante Moran Financial Advisors first reported a position in PACB in Q3 2022 and held it in 11 quarters. The position peaked at $14.8K in Q2 2023. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

Plante Moran Financial Advisors reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
Plante Moran Financial Advisors sold 4,450 Pacific Biosciences shares in Q2 2025, an estimated $5.25K.
Plante Moran Financial Advisors first reported a position in Pacific Biosciences in Q3 2022 and held it in 11 quarters.
Plante Moran Financial Advisors's Pacific Biosciences position peaked at $14.8K in Q2 2023.
207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.